Generics Not the Only Targets
Repurposing: Achilles Heel or Extra Leg to Stand On?
By Anette Breindl
Monday, May 9, 2011
In addition to the familiar stories of drugs that were developed in one indication and found success in another, such as sildenafil and thalidomide, there are regular reports of such repurposing on a smaller scale. Just last week, new data showed HIV drug Viracept (nelfinavir, Pfizer Inc.) chews up some solid tumors as well.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.